Notice of Effectiveness



>




X0101


EFFECT


33


LIVE



2020-12-04


16:01:00


S-3



0001624658


Allena Pharmaceuticals, Inc.


333-250992






The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Allena Pharmaceuticals, Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

Statement of acquisition of beneficial ownership by individuals - Jan. 25, 2022
Allena Pharmaceuticals Provides Clinical And Corporate Update ALLN-346, - Jan. 4, 2022

Auto Refresh

Feedback